PGEN Market Cap History

Below is a table of the PGEN market cap history going back to 10/31/2019:

Date PGEN Market Cap

Also see: PGEN Shares Outstanding History
and PGEN YTD Return
PGEN Historical Market Cap:
-18.27% CAGR
PGEN Historical Market Cap: +-18.27% CAGR

Mouse over chart for data details
10/31/2019 ...4/30/2024
Precigen is a clinical-stage biopharmaceutical company improving gene and cell therapies. Co. is utilizing proprietary technology platforms to develop product candidates designed to diseases in its therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. Co. is developing its clinical programs, including: PRGN-3005, PRGN-3006, and PRGN-3007, which are built on its UltraCAR-T platform; PRGN-2009 and PRGN-2012, which are based on its AdenoVerse immunotherapy platform; and AG019, which is built on its ActoBiotics platform. In addition, Co. has completed a Phase 1 study of INXN-4001, a non-viral triple-effector plasmid DNA, which is built on its UltraVector platform. We show 18 historical shares outstanding datapoints in our PGEN shares outstanding history coverage, used to compute PGEN market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing PGEN market cap history over the course of time is important for investors interested in comparing PGEN's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of PGEN versus a peer is one thing; comparing PGEN market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like PGEN can fluctuate over the course of history. With this page we aim to empower investors researching PGEN by allowing them to research the PGEN market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree PGEN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Precigen (PGEN) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

PGNX Market Cap History
PGNY Market Cap History
PHAS Market Cap History
PHAT Market Cap History
PHIO Market Cap History
PIII Market Cap History
PIRS Market Cap History
PKI Market Cap History
PLRX Market Cap History
PLSE Market Cap History
More Healthcare companies »


PGEN Market Cap History | | Copyright © 2017 - 2024, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Wait! Don't leave yet.
Want to receive our latest research absolutely free?

Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.